Macular Degeneration and Treatment

Mine Ün, Sedef Öztürk

DOI: 10.5606/jebms.2020.75600

Issue: 2020, Volume 1 - Issue 1
2498 2118

Scabies and Treatment

Büşra Aslan

DOI: 10.5606/jebms.2020.75603

Issue: 2020, Volume 1 - Issue 1
3558 2740

What Does CRISPR Technology Provide to Cancer Treatments?

Güner Yaman, Nilsu Çini, İlknur Altuntaş, Oytun Erbaş

DOI: 10.5606/jebms.2021.75637

Issue: 2021, Volume 2 - Issue 1
3324 1589

Multiple Myeloma Treatment

Edanur Tekin, Özge Çağlar, Elif Özyılmaz, Oytun Erbaş

DOI: 10.5606/jebms.2021.75658

Issue: 2021, Volume 2 - Issue 2
1925 1279

Glutamate and Migraine

Burak Mutlu, Ayşe Şiva Acar, Oytun Erbaş

DOI: 10.5606/jebms.2021.75664

Issue: 2021, Volume 2 - Issue 2
3900 1993

Metformin as Cancer Preventative and Therapeutic Agent

İlayda Üzümcü, Burak Akverdi, Elif Ünaldı, Oytun Erbaş

DOI: 10.5606/jebms.2022.1006

Issue: 2022, Volume 3 - Issue 1
3344 1250

Depression and Cardiovascular Disease: A Mutual Relationship

Bahar Işık,Oytun Erbaş

DOI: 10.5606/jebms.2023.1041

Issue: 2023, Volume 4 - Issue 1
3013 1363

Emerging Immunotherapeutic Approaches for Managing Metastasis

Alper Demirezen, Oytun Erbaş

DOI: 10.5606/jebms.2023.1050

Issue: 2023, Volume 4 - Issue 2
2891 1249

Revolutionizing Health Technologies: The Transformative Power of Stem Cells

Tutku Özaydın, Kerem Can Tunç, Oytun Erbaş

DOI: 10.5606/jebms.2024.1071

Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
3072 1059

Stem Cell Applications: A Promising Future for Autoimmune Diseases?

Öznur Safgöl, Oytun Erbaş

DOI: 10.5606/jebms.2024.1075

Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
3451 1274

Stem Cells in Surgery

Buse Kaptan, Oytun Erbaş

DOI: 10.5606/jebms.2024.1080

Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
2240 1104

Cancer Stem Cells

Alper Demirezen, Oytun Erbaş

DOI: 10.5606/jebms.2024.1083

Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
2934 1233

Histone Deacetylase Inhibitors in Cancer Treatment

Şule Demirkasaoğlu, Oytun Erbaş

DOI: 10.5606/jebms.2024.1102

Issue: 2024, Volume 5 - Issue 4
4106 1013